EUVIMEDEUVIMED entdecken
Crossref

Efficacy and Safety of Chemoimmunotherapy in Patients With Advanced Non-small Cell Lung Cancer With Pre-existing Interstitial Pneumonia and Low PD-L1 Expression

Aosa Sasada, Hayato Kawachi, Tadaaki Yamada, Tae Hata, Yasuhiro Goto, Akihiko Amano, Yoshiki Negi, Satoshi Watanabe, Naoki Furuya, Tomohiro Oba, Tatsuki Ikoma, Akira Nakao und 11 weitere

Anticancer Research · 2025

DOI: 10.21873/anticanres.17845 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Aosa Sasada und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, B7-H1 Antigen, Lung Neoplasms, Lung Diseases, Interstitial.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungB7-H1 AntigenLung NeoplasmsLung Diseases, InterstitialImmune Checkpoint InhibitorsImmunotherapyAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleAgedMiddle AgedRetrospective StudiesAged, 80 and overTreatment Outcome

Stichwörter der Autor:innen

Immune checkpoint inhibitorcombination therapyinterstitial pneumonianon-small cell lung cancerprogrammed death ligand 1propensity scoreretrospective study

Substanzen

B7-H1 AntigenCD274 protein, humanImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; tayamada@koto.kpu-m.ac.jp.
  • Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Japan.
  • Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
  • Department of Respiratory Medicine and Hematology, School of Medicine, Hyogo Medical University, Nishinomiya, Japan.
  • Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Zitieren

APA

Sasada, A., Kawachi, H., Yamada, T., Hata, T., Goto, Y., Amano, A., Negi, Y., Watanabe, S., Furuya, N., Oba, T., Ikoma, T., Nakao, A., Tanimura, K., Taniguchi, H., Yoshimura, A., Fukui, T., Murata, D., Kaira, K., Shiotsu, S., …, & Takayama, K. (2025). Efficacy and Safety of Chemoimmunotherapy in Patients With Advanced Non-small Cell Lung Cancer With Pre-existing Interstitial Pneumonia and Low PD-L1 Expression. Anticancer Research. https://doi.org/10.21873/anticanres.17845

Vancouver

Sasada A, Kawachi H, Yamada T, Hata T, Goto Y, Amano A, et al. Efficacy and Safety of Chemoimmunotherapy in Patients With Advanced Non-small Cell Lung Cancer With Pre-existing Interstitial Pneumonia and Low PD-L1 Expression. Anticancer Research. 2025. doi:10.21873/anticanres.17845

BibTeX
@article{Sasada2025,
  author = {Sasada, Aosa and Kawachi, Hayato and Yamada, Tadaaki and Hata, Tae and Goto, Yasuhiro and Amano, Akihiko and Negi, Yoshiki and Watanabe, Satoshi and Furuya, Naoki and Oba, Tomohiro and Ikoma, Tatsuki and Nakao, Akira and Tanimura, Keiko and Taniguchi, Hirokazu and Yoshimura, Akihiro and Fukui, Tomoya and Murata, Daiki and Kaira, Kyoichi and Shiotsu, Shinsuke and Okada, Asuka and Chihara, Yusuke and Kijima, Takashi and Takayama, Koichi},
  title = {Efficacy and Safety of Chemoimmunotherapy in Patients With Advanced Non-small Cell Lung Cancer With Pre-existing Interstitial Pneumonia and Low PD-L1 Expression},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17845}
}
Kostenlos starten →